Table 1. Clinical characteristics of patients in STN-DBS group and medicine group.
| Characteristic | DBS Group (n = 16) | Medicine Group (n = 20) | t/χ2 | P |
|---|---|---|---|---|
| Age, years | 60.25±5.56 | 57.88±6.98 | 1.33 | 0.26 |
| Gender, male | 8,50% | 8,40% | 0.36 | 0.55 |
| Duration of PD, years | 10.38±4.33 | 12.85±4.25 | 1.71 | 0.10 |
| LEDD, mg | ||||
| preoperation | 1225.63±714.81 | 1200.80±714.81 | 0.11 | 0.91 |
| 6 months | 503.13±140.50 | 1280.85±580.05 | 5.79 | 0.00* |
| 12 months | 464.06±139.03 | 1270.55±688.28 | 4.86 | 0.00* |
| PDQ-39 | ||||
| preoperation | 81.88±27.97 | 82.64±32.16 | 0.08 | 0.94 |
| 6 months | 44.63±22.38 | 78.30±28.05 | 4.01 | 0.00* |
| 12 months | 38.56±15.34 | 80.94±38.03 | 4.54 | 0.00* |
| MDS-UPDRS III preoperation | ||||
| Med-off | 59.38±17.07 | 58.87±14.84 | 0.09 | 0.93 |
| Med-on | 41.63±11.55 | 39.76±13.29 | 0.45 | 0.65 |
*P<0.01 means significant differences.